Minor
Suspected
Description
Carbamazepine may modestly affect glucose homeostasis and potentially interact with metformin's antidiabetic effect through metabolic mechanisms.
Mechanism
Carbamazepine has reported hyperglycemic effects and may impair insulin secretion; the interaction with metformin's biguanide mechanism is primarily pharmacodynamic.
Clinical Significance
The interaction is generally minor; blood glucose monitoring is advisable when initiating or stopping carbamazepine in diabetic patients.
Management
Monitor blood glucose when initiating or changing carbamazepine doses; metformin dose adjustment is rarely required.